相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coinfections of Two Strains of NDM-1-and OXA-232-Coproducing Kiebsiella pneumoniae in a Kidney Transplant Patient
Deisy A. Contreras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient
Zain Alamarat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Cefiderocol for extensively-drug resistant gram-negative bacterial infections: real-world experience from a case-series and review of the literature
Sandra Zingg et al.
Open Forum Infectious Diseases (2020)
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report
Enrico Maria Trecarichi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin
Takayuki Katsube et al.
CLINICAL INFECTIOUS DISEASES (2019)
Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
Robert A. Bonomo
CLINICAL INFECTIOUS DISEASES (2019)
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study
Matteo Bassetti et al.
INFECTION AND DRUG RESISTANCE (2019)
Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa
Jonathan D. Edgeworth et al.
CLINICAL INFECTIOUS DISEASES (2019)
Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
Yutaka Saisho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
Takayuki Katsube et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Dalbavancin and telavancin:: novel lipoglycopeptides for the treatment of Gram-positive infections
George G. Zhanel et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
分享论文
